Clinical trials
Terminated Recurrence trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Cancerologie de l'Ouest | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Boston University | 1 |
| British Columbia Cancer Agency | 1 |
| Cantonal Hospital of St. Gallen | 1 |
| Chinese University of Hong Kong | 1 |
| Emory University | 1 |
| Guangzhou Bio-gene Technology Co., Ltd | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hangzhou Cheetah Cell Therapeutics Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 25 |
| Leukemia | 6 |
| Multiple Myeloma | 5 |
| Burkitt Lymphoma | 4 |
| Dendritic Cell Sarcoma, Interdigitating | 4 |
| Leukemia, Myeloid, Accelerated Phase | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia, Myeloid, Chronic-Phase | 4 |
| Leukemia, Myelomonocytic, Juvenile | 4 |
| Lymphoma | 4 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.